Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AUTHOR REPLY.
Kern SQ, Speir RW, Tong Y, Kaimakliotis H, Masterson TA, Bihrle R, Foster R, Koch MO, Cary C. Kern SQ, et al. Urology. 2021 Jun;152:189. doi: 10.1016/j.urology.2020.12.040. Urology. 2021. PMID: 34112344 No abstract available.
Nephron-sparing management of upper tract urothelial carcinoma.
Farrow JM, Kern SQ, Gryzinski GM, Sundaram CP. Farrow JM, et al. Among authors: kern sq. Investig Clin Urol. 2021 Jul;62(4):389-398. doi: 10.4111/icu.20210113. Investig Clin Urol. 2021. PMID: 34190434 Free PMC article. Review.
Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.
Tachibana I, Vasquez R, Mahmoud M, Kern SQ, Patel RS, King J, Adra N, Boris RS, Cary C, Rice KR. Tachibana I, et al. Among authors: kern sq. Urol Oncol. 2022 Nov;40(11):495.e11-495.e17. doi: 10.1016/j.urolonc.2022.08.006. Epub 2022 Sep 22. Urol Oncol. 2022. PMID: 36154800
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
Tachibana I, Kern SQ, Douglawi A, Tong Y, Mahmoud M, Masterson TA, Adra N, Foster RS, Einhorn LH, Cary C. Tachibana I, et al. Among authors: kern sq. Eur Urol. 2023 Jan;83(1):e20-e21. doi: 10.1016/j.eururo.2022.09.018. Epub 2022 Oct 1. Eur Urol. 2023. PMID: 36195478 No abstract available.
23 results